Market Overview - The cosmetics sector increased by 0.2% on November 13, with Jinsheng New Materials leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Individual Stock Performance - Jinsheng New Materials (300849) closed at 16.16, up 2.08% with a trading volume of 59,500 shares and a transaction value of 95.82 million yuan [1] - Shuiyang Co. (300740) closed at 21.51, up 2.04% with a trading volume of 147,200 shares and a transaction value of 314 million yuan [1] - Beitaini (300957) closed at 43.24, up 1.08% with a trading volume of 35,900 shares and a transaction value of 154 million yuan [1] - Other notable stocks include Furuida (600223) at 7.98 (+0.63%), Qingsong Co. (300132) at 8.12 (+0.37%), and Qingdao Kingway (002094) at 7.80 (+0.26%) [1] Capital Flow Analysis - The cosmetics sector experienced a net outflow of 56.57 million yuan from institutional investors and 32.11 million yuan from retail investors, while individual investors saw a net inflow of 88.67 million yuan [2] - The capital flow for individual stocks shows that Shuiyang Co. had a net inflow of 21.64 million yuan from institutional investors, while other stocks like Huaye Fragrance (300886) and Kesheng Co. (300856) faced net outflows [3]

丸美生物表示，公司将充分考虑现有股东的利益和境内外资本市场的情况，在股东大会决议有效期内选 择适当的时机和发行窗口完成本次发行上市， 丸美生物同时宣布，董事会同意聘请安永为公司拟香港发行上市的审计机构。 丸美生物成立于2002年，专注于眼部护理和生物抗衰老的研究，建设有广州·东京·上海研发三擎科研中 心 ，12大研究平台，致力于以全球领先技术为基点，研发高品质产品。公司旗下拥有"MARUBI丸美" "PASSIONAL LOVER" "CHUNJI春纪" "丸美东京" 四大品牌。公司多次评为国家级高新技术企业，连续 多次蝉联《Womens' Wear Daily》全球美容企业100强。 | 高:34.36 | 今开:34.36 | 涨停:37.40 | 成交量:8841手 | | --- | --- | --- | --- | | 低: 33.76 | 昨收:34.00 | 跌停:30.60 | 成交额:3003.02万 | | 比: 0.57 | 换手:0.22% | 市盈率(动):41.94 | 市盈率(TTM): 39.3 | | 比: -9.68% | 振幅:1.76% | 市盈率(静):39.92 ...

Focus on Chengtun Mining - Company plans to invest approximately 1.423 billion RMB (19.995 million USD) in its subsidiary Chengtun Gold International through its wholly-owned subsidiary Hongsheng International Resources [1] Focus on Century Huatong - Company intends to repurchase shares worth between 500 million to 1 billion RMB, with a maximum repurchase price of 28.77 RMB per share [2] Focus on ST Zhongdi - Company stock experienced a significant price increase of 153.19% from October 16 to November 12, 2025, leading to a trading suspension for verification starting November 13, 2025 [3] Performance Highlights - BeiGene reported a revenue of 27.595 billion RMB for the first three quarters of 2025, marking a year-on-year growth of 44.2%, with a net profit of 1.139 billion RMB [4] Capital Increase & Restructuring - *ST Lian Stone received court approval for its restructuring plan, entering the execution phase after the termination of the restructuring process [5] Important Matters - Tuosda is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries [6] - North Medical's chairman and president were arrested for criminal charges, but the company's control and operations remain stable [7] - Nanjing Public Utilities is transferring 43.731 million shares, accounting for 7.61% of total shares, to Nanjing Innovation Investment Group for approximately 300 million RMB [8] Company Developments - Kaige Precision Machinery is establishing a joint venture with Zhangjiagang Wuyue Special Materials Technology, with an investment of 1 billion RMB for high-end component projects [9] - Stable Medical is investing approximately 2 billion RMB in a new production base for cotton non-woven fabric [10] - Fuchun Environmental is co-investing 116 million RMB in a combined heat and power project in Hubei [10] - Xingsheng Zhihui is collaborating with Beijing Automotive Group for resource sharing in the new energy vehicle sector [10] Stock Trading Updates - Huazhong Silver's subsidiary is undergoing a year-end maintenance shutdown, expected to last 20 days, with no impact on annual production plans [11] - San Yuan Co. clarified that its seasonal product, milk skin candy, has minimal revenue impact [12] - Chongqing Beer plans to distribute a cash dividend of 1.30 RMB per share, totaling approximately 629 million RMB [12] Stock Suspension - ST Zhongdi's stock is suspended for verification due to significant price fluctuations [15]

Group 1: Company Developments - Marubi Biotechnology plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance capital strength and international competitiveness [1] - Zhejiang Shimai Pharmaceutical Co., Ltd. has submitted an IPO application to the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor [3] - BeiGene reported third-quarter revenue of 10.077 billion yuan, a year-on-year increase of 41.1%, and a net profit of 689 million yuan, marking a turnaround from loss [4] - Tencent Music announced third-quarter total revenue of 8.46 billion yuan, a year-on-year increase of 20.6%, with adjusted net profit rising by 27.7% [5] Group 2: Market Trends - Bilibili reported a 109% year-on-year increase in the number of clients advertising during the Double 11 shopping festival, with GMV for products priced over 1,000 yuan increasing by 63% [2] - The average new customer rate across all industries on Bilibili reached 55%, with certain sectors like watches and beauty exceeding 60% [2] Group 3: Industry Insights - The Bank of Korea's governor indicated that future interest rate changes will depend on upcoming data, maintaining a stance of monetary easing [6][7] - The National Energy Administration of China is exploring the construction of energy storage systems to enhance the integration of renewable energy [7] - The first electric vertical take-off and landing flying car factory in Guangzhou has entered trial production, marking a significant step towards large-scale manufacturing in the low-altitude economy [8]

Core Viewpoint - Mamei Biotechnology (603983.SH) plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its capital strength and overseas financing capabilities, aiming to accelerate its international business strategy [1] Group 1 - The company intends to issue H-shares to improve its overall competitiveness and support its internationalization strategy [1] - The issuance will consider the interests of existing shareholders and the conditions of domestic and international capital markets [1] - The timing and specifics of the issuance will be determined by the board of directors based on market conditions and regulatory approvals within a 24-month period following the shareholders' meeting resolution [1]

Group 1: Company Developments - Marubi Biotechnology plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance capital strength and international competitiveness [1] - Zhejiang Shimai Pharmaceutical Co., Ltd. has submitted an IPO application to the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor [3] - BeiGene reported a third-quarter revenue of 10.077 billion yuan, a year-on-year increase of 41.1%, and a net profit of 689 million yuan, marking a turnaround from loss [4] - Tencent Music announced a third-quarter total revenue of 8.46 billion yuan, a year-on-year increase of 20.6%, with adjusted net profit rising by 27.7% [5] Group 2: Market Trends - Bilibili reported a 109% year-on-year increase in the number of clients advertising during Double 11, with GMV for products priced over 1,000 yuan increasing by 63% [2] - The average new customer rate across all industries on Bilibili reached 55%, with certain sectors like watches and beauty exceeding 60% [2] Group 3: Industry Insights - The Bank of Korea's governor stated that future interest rate changes will depend on upcoming data, maintaining a stance of monetary policy easing [9] - The National Energy Administration of China is exploring the construction of energy storage systems to enhance the integration of renewable energy [9] - The first electric vertical take-off and landing flying car factory in Guangzhou has entered trial production, marking a significant step towards large-scale manufacturing in the low-altitude economy [10]

广东丸美生物技术股份有限公司 广东丸美生物技术股份有限公司 股东会议事规则（草案） 股东会议事规则（草案） （H 股发行并上市后适用） 第一章 总 则 第一条 为规范广东丸美生物技术股份有限公司（以下简称"公司"）行为， 维护公司股东的合法权益，保证股东会依法行使职权，根据《中华人民共和国公 司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券 法》"）、《上市公司股东会规则》、《上海证券交易所股票上市规则》、《香港联合交 易所有限公司证券上市规则》（以下简称"《香港上市规则》"）等相关法律、法规、 规范性文件以及《广东丸美生物技术股份有限公司章程》（以下简称"《公司章程》"） 的规定，制定《广东丸美生物技术股份有限公司股东会议事规则》（以下简称"本 规则"）。 第二条 公司股东会的召集、提案、通知、召开等事项适用本规则。 第三条 公司应当严格按照法律、行政法规、公司股票上市地证券监管规则、 《公司章程》及本规则的相关规定召开股东会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当 勤勉尽责，确保股东会正常召开和依法行使职权。 第四条 股东 ...

广东丸美生物技术股份有限公司 董事会提名委员会工作细则（草案） 广东丸美生物技术股份有限公司 董事会提名委员会工作细则（草案） （H股发行并上市后适用） 第一章 总则 第一条 为规范广东丸美生物技术股份有限公司（以下简称"公司"）董事和 总经理等高级管理人员的选聘工作，优化董事会组成，完善公司治理结构，根据 《中华人民共和国公司法》《上市公司治理准则》《香港联合交易所有限公司证 券上市规则》《广东丸美生物技术股份有限公司章程》（以下简称"公司章程"） 及其他有关规定，公司董事会特设立提名委员会，并制定本工作细则。 第二条 提名委员会是董事会下设的专门工作机构，主要负责对公司董事和高 级管理人员的人选、选择标准和程序进行选择并提出建议。 第二章 人员组成 第三条 提名委员会成员由三名董事组成，其中独立董事应当过半数，并且需 要包括至少一名不同性别的董事。 第四条 提名委员会委员由董事长提名，并由董事会选举产生。 第五条 提名委员会设一名主任委员作为委员会召集人，由独立董事委员担任， 负责主持提名委员会工作。 第六条 提名委员会任期与董事会任期一致，委员任期届满，连选可以连任。 在该任期内，如有委员不再担任公司董 ...

广东丸美生物技术股份有限公司 内幕信息知情人登记管理制度（草案） 广东丸美生物技术股份有限公司 内幕信息知情人登记管理制度（草案） （H 股发行并上市后适用） 第一章 总则 第一条 为规范广东丸美生物技术股份有限公司（以下简称"公司"）内幕 信息管理，加强内幕信息保密工作，有效防范内幕交易等违法违规行为，维护信 息披露的公开、公平、公正原则，保护投资者的合法权益，根据《中华人民共和 国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简 称"《证券法》"）、中国证券监督管理委员会（以下简称"中国证监会"）《上 市公司信息披露管理办法》及《上市公司监管指引第 5 号——上市公司内幕信 息知情人登记管理制度》、《上海证券交易所股票上市规则》（以下简称"《股 票上市规则》"）《香港联合交易所有限公司证券上市规则》、香港《证券及期 货条例》（香港法例第 571 章）（以下简称《证券及期货条例》）等法律、行政 法规、部门规章、规范性文件和《广东丸美生物技术股份有限公司章程》（以下 简称"公司章程"）、《广东丸美生物技术股份有限公司信息披露管理制度》等 有关规定，结合公司实际情况，制定本制度。 第二条 公 ...

广东丸美生物技术股份有限公司 信息披露管理制度（草案） 广东丸美生物技术股份有限公司 信息披露管理制度（草案） （H股发行并上市后适用） 第一章 总则 第一条 为规范广东丸美生物技术股份有限公司（以下简称"公司"）的信 息披露行为，保护公司、股东及投资者的合法权益，根据《中华人民共和国公 司法》、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司信息披 露管理办法》、《上海证券交易所股票上市规则》（以下简称"《股票上市规则》"）、 《上海证券交易所上市公司自律监管指引第 2 号——信息披露事务管理》《香港 联合交易所有限公司证券上市规则》（以下简称"《香港上市规则》"，其中"香 港联合交易所有限公司"以下简称"香港联交所"）等相关法律、法规、规范性 文件以及《广东丸美生物技术股份有限公司章程》（以下简称"公司章程"）的 规定，制定本制度。 第二条 公司应当根据法律、法规、规范性文件、公司章程及中国证券监督 管理委员会（以下简称"中国证监会"）、上海证券交易所（以下简称"上交所"）、 香港联交所的相关规定，履行信息披露义务。 第三条 本规定所称的信息披露，是指将可能对公司证券及其衍生品种交易 价格产 ...